Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 9, 2020 · 10-Q · 40 days after period end · 0001069530-20-000066
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$1.43M | -$697.00K | -$1.27M | -$2.59M |
| EPS Diluted | -$0.06 | -$0.04 | -$0.11 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end
